Keita Morimoto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Keita Morimoto has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Takashi Yokoo
Division of Nephrology and Hypertension, Department of Internal Medicine, Jikei University School of medicine, Tokyo, Japan
9 shared publications - Kenji Matsui
Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan
6 shared publications - Shuichiro Yamanaka
Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan
6 shared publications - Yoshitaka Kinoshita
Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan
6 shared publications - Yuka Inage
Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan
6 shared publications - Eiji Kobayashi
Division of Basic Science, School of Veterinary Nursing and Technology, Nippon Veterinary and Life Science University, 1-7-1 Kyonan-cho, Musashino-shi 180-8602, Tokyo, Japan
4 shared publications
Latest Publications
- 19 March 2025
- Published by Elsevier in Kidney International
- Vol. 107 (4) , 757-759
Reevaluating anti-nephrin autoantibodies by ELISA using human embryonic kidney–derived recombinant extracellular domain of human nephrin
- 19 March 2025
- Published by Elsevier in Kidney International
- Vol. 107 (4) , 757-759
Reevaluating anti-nephrin autoantibodies by ELISA using human embryonic kidney–derived recombinant extracellular domain of human nephrin
- Open Access
- 3 March 2025
- Published by Springer Nature in Communications Biology
- Vol. 8 (1) , 1-11
Fetal-to-fetal kidney transplantation in utero
Potter sequence consists of various symptoms associated with renal dysplasia. For bilateral renal agenesis, there is no hope of survival. As a novel therapeutic approach for Potter sequence, we develop a unique approach of “transplantation of fetal kidneys from a different species during the fetal stage.” In this study, we first validate the approach using allogeneic transplantation. Fetal kidneys with bladders from green fluorescent protein-expressing rats (embryonic day 14.0–16.5) are subcutaneously transplanted into allogeneic rat fetuses in utero (embryonic day 18.0–18.5). After birth, the transplanted fetal kidneys are confirmed to have urine production capability. Furthermore, long-term (up to 150 days) urine production is sustained. Next, we perform xenotransplantation. The transplantation of mouse fetal kidneys into rat fetuses in utero leads to the maturation of renal tissue structures. We demonstrate organ transplantation into in utero fetuses using fetal kidneys as donor organs for fetal therapy.
- 3 March 2025
- Published by Springer Nature in Communications Biology
- Vol. 8 (1) , 1-11
Open AccessFetal-to-fetal kidney transplantation in utero
Potter sequence consists of various symptoms associated with renal dysplasia. For bilateral renal agenesis, there is no hope of survival. As a novel therapeutic approach for Potter sequence, we develop a unique approach of “transplantation of fetal kidneys from a different species during the fetal stage.” In this study, we first validate the approach using allogeneic transplantation. Fetal kidneys with bladders from green fluorescent protein-expressing rats (embryonic day 14.0–16.5) are subcutaneously transplanted into allogeneic rat fetuses in utero (embryonic day 18.0–18.5). After birth, the transplanted fetal kidneys are confirmed to have urine production capability. Furthermore, long-term (up to 150 days) urine production is sustained. Next, we perform xenotransplantation. The transplantation of mouse fetal kidneys into rat fetuses in utero leads to the maturation of renal tissue structures. We demonstrate organ transplantation into in utero fetuses using fetal kidneys as donor organs for fetal therapy.
- 30 January 2025
- Published by Springer Nature in Pediatric Nephrology
- Vol. 40 (10) , 3037-3044
Recent progress in xenotransplantation and its application to pediatric kidney disease
Patients with kidney failure require dialysis or kidney transplantation. Kidney transplantation offers great benefits, including reduced mortality; however, many patients who wish to undergo kidney transplantation are unable to do so due to a shortage of donor organs. This shortage is a global issue, and xenotransplantation has emerged as a potential solution. The history of xenotransplantation is characterized by overcoming the immunological challenge of hyperacute rejection. Recently, breakthroughs such as gene-edited pigs and novel immunosuppressants have successfully lowered rejection rates. Recent clinical studies have reported transplants in patients diagnosed with brain death, and in March 2024, a gene-edited pig kidney was transplanted into a patient with kidney failure at Massachusetts General Hospital, marking the first instance of a gene-edited xenotransplantation into a living patient. Our research focuses on applying xenotransplantation in pediatric and obstetric fields, specifically exploring fetal therapy using pig fetal kidneys. We have long been researching the development of a novel kidney replacement therapy involving the transplantation of fetal pig kidneys. Fetal pig kidneys have the advantage of not requiring vascular anastomosis and are less likely to be rejected compared to adult pig kidneys. Currently, we are advancing nonhuman primate studies aimed at clinical trials of pig fetal kidney transplant therapy for fetuses diagnosed with Potter syndrome, characterized by bilateral kidney agenesis. We sincerely hope that xenotransplantation will soon become a viable treatment option for adult, pediatric, and fetal patients with kidney failure. Graphical Abstract A higher resolution version of the Graphical abstract is available as Supplementary information
- 30 January 2025
- Published by Springer Nature in Pediatric Nephrology
- Vol. 40 (10) , 3037-3044
Recent progress in xenotransplantation and its application to pediatric kidney disease
Patients with kidney failure require dialysis or kidney transplantation. Kidney transplantation offers great benefits, including reduced mortality; however, many patients who wish to undergo kidney transplantation are unable to do so due to a shortage of donor organs. This shortage is a global issue, and xenotransplantation has emerged as a potential solution. The history of xenotransplantation is characterized by overcoming the immunological challenge of hyperacute rejection. Recently, breakthroughs such as gene-edited pigs and novel immunosuppressants have successfully lowered rejection rates. Recent clinical studies have reported transplants in patients diagnosed with brain death, and in March 2024, a gene-edited pig kidney was transplanted into a patient with kidney failure at Massachusetts General Hospital, marking the first instance of a gene-edited xenotransplantation into a living patient. Our research focuses on applying xenotransplantation in pediatric and obstetric fields, specifically exploring fetal therapy using pig fetal kidneys. We have long been researching the development of a novel kidney replacement therapy involving the transplantation of fetal pig kidneys. Fetal pig kidneys have the advantage of not requiring vascular anastomosis and are less likely to be rejected compared to adult pig kidneys. Currently, we are advancing nonhuman primate studies aimed at clinical trials of pig fetal kidney transplant therapy for fetuses diagnosed with Potter syndrome, characterized by bilateral kidney agenesis. We sincerely hope that xenotransplantation will soon become a viable treatment option for adult, pediatric, and fetal patients with kidney failure. Graphical Abstract A higher resolution version of the Graphical abstract is available as Supplementary information
- Open Access
- 1 January 2025
- Published by Japanese Society for Pediatric Nephrology in Japanese journal of pediatric nephrology
- Vol. 38, rv.24-018
Can Pediatric Renal Disease be Eligible for Xenotransplantation?
現在,成人腎不全患者に対するブタ成獣異種移植が米国などで進められているが,患者への強力な免疫抑制や,ブタを維持するための広大な施設や多額の資金が必要である.一方,胎仔腎は低免疫原性を有し,移植臓器を提供するブタの施設規模や資金を縮小することができる.我々は,ブタ胎仔腎移植を腎性羊水過少シークエンスに臨床応用することを提唱している.腎性羊水過少シークエンスの胎児の皮下にブタ胎仔腎を移植し,成長させ,尿を産生させる.出生後,一時的に尿産生・電解質管理をブタ胎仔腎に頼り,出生後の呼吸・循環動態が不安定な時期の腎代替療法を回避する.最終的には腎代替療法を導入するが,この方法によって出生直後から腎代替療法がより安全にできるまでの架け橋治療をすることが目的である.胎児に対する異種移植は倫理面でより慎重になる必要があり,多角的な議論を重ね,臨床応用への道筋を慎重に探っていくことが重要だと考えている.
- 1 January 2025
- Published by Japanese Society for Pediatric Nephrology in Japanese journal of pediatric nephrology
- Vol. 38, rv.24-018
Open AccessCan Pediatric Renal Disease be Eligible for Xenotransplantation?
現在,成人腎不全患者に対するブタ成獣異種移植が米国などで進められているが,患者への強力な免疫抑制や,ブタを維持するための広大な施設や多額の資金が必要である.一方,胎仔腎は低免疫原性を有し,移植臓器を提供するブタの施設規模や資金を縮小することができる.我々は,ブタ胎仔腎移植を腎性羊水過少シークエンスに臨床応用することを提唱している.腎性羊水過少シークエンスの胎児の皮下にブタ胎仔腎を移植し,成長させ,尿を産生させる.出生後,一時的に尿産生・電解質管理をブタ胎仔腎に頼り,出生後の呼吸・循環動態が不安定な時期の腎代替療法を回避する.最終的には腎代替療法を導入するが,この方法によって出生直後から腎代替療法がより安全にできるまでの架け橋治療をすることが目的である.胎児に対する異種移植は倫理面でより慎重になる必要があり,多角的な議論を重ね,臨床応用への道筋を慎重に探っていくことが重要だと考えている.
- Open Access
- 20 September 2024
- Published by Springer Nature in Research Square
Fetal Kidney Transplantation into In Utero Fetuses
Potter sequence consists of various symptoms associated with renal dysplasia. For bilateral renal agenesis, there is no hope of survival. As a novel therapeutic approach for Potter sequence, we developed a unique approach of “transplantation of fetal kidneys from a different species during the fetal period.” In this study, we first validated the approach using allogeneic transplantation. Fetal kidneys with bladders from green fluorescent protein-expressing rats (embryonic day 14.0–16.5) were subcutaneously transplanted into allogeneic rat fetuses in utero (embryonic day 18.0–18.5). After birth, the transplanted fetal kidneys were confirmed to have urine production capability. Furthermore, long-term (up to 150 days) urine production was sustained. Next, we performed xenotransplantation. The transplantation of mouse fetal kidneys into rat fetuses in utero led to the maturation of renal tissue structures. We demonstrated organ transplantation into in utero fetuses using fetal kidneys as donor organs for fetal therapy.
- 20 September 2024
- Published by Springer Nature in Research Square
Open AccessFetal Kidney Transplantation into In Utero Fetuses
Potter sequence consists of various symptoms associated with renal dysplasia. For bilateral renal agenesis, there is no hope of survival. As a novel therapeutic approach for Potter sequence, we developed a unique approach of “transplantation of fetal kidneys from a different species during the fetal period.” In this study, we first validated the approach using allogeneic transplantation. Fetal kidneys with bladders from green fluorescent protein-expressing rats (embryonic day 14.0–16.5) were subcutaneously transplanted into allogeneic rat fetuses in utero (embryonic day 18.0–18.5). After birth, the transplanted fetal kidneys were confirmed to have urine production capability. Furthermore, long-term (up to 150 days) urine production was sustained. Next, we performed xenotransplantation. The transplantation of mouse fetal kidneys into rat fetuses in utero led to the maturation of renal tissue structures. We demonstrated organ transplantation into in utero fetuses using fetal kidneys as donor organs for fetal therapy.
- Open Access
- 27 April 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (9) , 4793
Fetal Kidney Grafts and Organoids from Microminiature Pigs: Establishing a Protocol for Production and Long-Term Cryopreservation
Fetal organs and organoids are important tools for studying organ development. Recently, porcine organs have garnered attention as potential organs for xenotransplantation because of their high degree of similarity to human organs. However, to meet the prompt demand for porcine fetal organs by patients and researchers, effective methods for producing, retrieving, and cryopreserving pig fetuses are indispensable. Therefore, in this study, to collect fetuses for kidney extraction, we employed cesarean sections to preserve the survival and fertility of the mother pig and a method for storing fetal kidneys by long-term cryopreservation. Subsequently, we evaluated the utility of these two methods. We confirmed that the kidneys of pig fetuses retrieved by cesarean section that were cryopreserved for an extended period could resume renal growth when grafted into mice and were capable of forming renal organoids. These results demonstrate the usefulness of long-term cryopreserved fetal pig organs and strongly suggest the effectiveness of our comprehensive system of pig fetus retrieval and fetal organ preservation, thereby highlighting its potential as an accelerator of xenotransplantation research and clinical innovation.
- 27 April 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (9) , 4793
Open AccessFetal Kidney Grafts and Organoids from Microminiature Pigs: Establishing a Protocol for Production and Long-Term Cryopreservation
Fetal organs and organoids are important tools for studying organ development. Recently, porcine organs have garnered attention as potential organs for xenotransplantation because of their high degree of similarity to human organs. However, to meet the prompt demand for porcine fetal organs by patients and researchers, effective methods for producing, retrieving, and cryopreserving pig fetuses are indispensable. Therefore, in this study, to collect fetuses for kidney extraction, we employed cesarean sections to preserve the survival and fertility of the mother pig and a method for storing fetal kidneys by long-term cryopreservation. Subsequently, we evaluated the utility of these two methods. We confirmed that the kidneys of pig fetuses retrieved by cesarean section that were cryopreserved for an extended period could resume renal growth when grafted into mice and were capable of forming renal organoids. These results demonstrate the usefulness of long-term cryopreserved fetal pig organs and strongly suggest the effectiveness of our comprehensive system of pig fetus retrieval and fetal organ preservation, thereby highlighting its potential as an accelerator of xenotransplantation research and clinical innovation.
- Open Access
Exploration of Preservation Methods for Utilizing Porcine Fetal-Organ-Derived Cells in Regenerative Medicine Research
Human pluripotent stem cells have been employed in generating organoids, yet their immaturity compared to fetal organs and the limited induction of all constituent cell types remain challenges. Porcine fetal progenitor cells have emerged as promising candidates for co-culturing with human progenitor cells in regeneration and xenotransplantation research. This study focused on identifying proper preservation methods for porcine fetal kidneys, hearts, and livers, aiming to optimize their potential as cell sources. Extracted from fetal microminiature pigs, these organs were dissociated before and after cryopreservation–thawing, with subsequent cell quality evaluations. Kidney cells, dissociated and aggregated after vitrification in a whole-organ form, were successfully differentiated into glomeruli and tubules in vivo. In contrast, freezing hearts and livers before dissociation yielded suboptimal results. Heart cells, frozen after dissociation, exhibited pulsating heart muscle cells similar to non-frozen hearts. As for liver cells, we developed a direct tissue perfusion technique and successfully obtained highly viable liver parenchymal cells. Freezing dissociated liver cells, although inferior to their non-frozen counterparts, maintained the ability for colony formation. The findings of this study provide valuable insights into suitable preservation methods for porcine fetal cells from kidneys, hearts, and livers, contributing to the advancement of regeneration and xenotransplantation research.
Open AccessExploration of Preservation Methods for Utilizing Porcine Fetal-Organ-Derived Cells in Regenerative Medicine Research
Human pluripotent stem cells have been employed in generating organoids, yet their immaturity compared to fetal organs and the limited induction of all constituent cell types remain challenges. Porcine fetal progenitor cells have emerged as promising candidates for co-culturing with human progenitor cells in regeneration and xenotransplantation research. This study focused on identifying proper preservation methods for porcine fetal kidneys, hearts, and livers, aiming to optimize their potential as cell sources. Extracted from fetal microminiature pigs, these organs were dissociated before and after cryopreservation–thawing, with subsequent cell quality evaluations. Kidney cells, dissociated and aggregated after vitrification in a whole-organ form, were successfully differentiated into glomeruli and tubules in vivo. In contrast, freezing hearts and livers before dissociation yielded suboptimal results. Heart cells, frozen after dissociation, exhibited pulsating heart muscle cells similar to non-frozen hearts. As for liver cells, we developed a direct tissue perfusion technique and successfully obtained highly viable liver parenchymal cells. Freezing dissociated liver cells, although inferior to their non-frozen counterparts, maintained the ability for colony formation. The findings of this study provide valuable insights into suitable preservation methods for porcine fetal cells from kidneys, hearts, and livers, contributing to the advancement of regeneration and xenotransplantation research.
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Acta Cirurgica Brasileira
- Vol. 39, e390624
Maturation and development of fetal pig intestinal tissue in immunodeficient mice
This study aimed to compare the degree of maturation and development of fetal pig segmental intestinal tissue with that of spheroids created by in-vitro reaggregation of dissociated fetal intestinal cells after transplantation into immunodeficient mice.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Acta Cirurgica Brasileira
- Vol. 39, e390624
Open AccessMaturation and development of fetal pig intestinal tissue in immunodeficient mice
This study aimed to compare the degree of maturation and development of fetal pig segmental intestinal tissue with that of spheroids created by in-vitro reaggregation of dissociated fetal intestinal cells after transplantation into immunodeficient mice.
- Open Access
- 15 March 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (6) , 2293
Cryopreservation of Fetal Porcine Kidneys for Xenogeneic Regenerative Medicine
Kidney xenotransplantation has been attracting attention as a treatment option for end-stage renal disease. Fetal porcine kidneys are particularly promising grafts because they can reduce rejection through vascularization from host vessels. We are proposing xenogeneic regenerative medicine using fetal porcine kidneys injected with human nephron progenitor cells. For clinical application, it is desirable to establish reliable methods for the preservation and quality assessment of grafts. We evaluated the differentiation potency of vitrified porcine fetal kidneys compared with nonfrozen kidneys, using an in vivo differentiation model. Fetal porcine kidneys connected to the bladder were frozen via vitrification and stored in liquid nitrogen. Several days later, they were thawed and transplanted under the retroperitoneum of immunocompromised mice. After 14 days, the frozen kidneys grew and differentiated into mature nephrons, and the findings were comparable to those of nonfrozen kidneys. In conclusion, we demonstrated that the differentiation potency of vitrified fetal porcine kidneys could be evaluated using this model, thereby providing a practical protocol to assess the quality of individual lots.
- 15 March 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (6) , 2293
Open AccessCryopreservation of Fetal Porcine Kidneys for Xenogeneic Regenerative Medicine
Kidney xenotransplantation has been attracting attention as a treatment option for end-stage renal disease. Fetal porcine kidneys are particularly promising grafts because they can reduce rejection through vascularization from host vessels. We are proposing xenogeneic regenerative medicine using fetal porcine kidneys injected with human nephron progenitor cells. For clinical application, it is desirable to establish reliable methods for the preservation and quality assessment of grafts. We evaluated the differentiation potency of vitrified porcine fetal kidneys compared with nonfrozen kidneys, using an in vivo differentiation model. Fetal porcine kidneys connected to the bladder were frozen via vitrification and stored in liquid nitrogen. Several days later, they were thawed and transplanted under the retroperitoneum of immunocompromised mice. After 14 days, the frozen kidneys grew and differentiated into mature nephrons, and the findings were comparable to those of nonfrozen kidneys. In conclusion, we demonstrated that the differentiation potency of vitrified fetal porcine kidneys could be evaluated using this model, thereby providing a practical protocol to assess the quality of individual lots.
- Open Access
- 10 December 2018
- Published by Springer Nature in BMC Nephrology
- Vol. 19 (1) , 350
Maternally inherited diabetes and deafness complicated by mesangial galactose-deficient IgA1 deposits: a case report
Maternally inherited diabetes and deafness (MIDD), a mitochondrial genetic disorder, typically affects the kidneys and results in end-stage renal disease. Early diagnosis of MIDD is challenging when renal manifestations precede other key clinical features such as diabetes and deafness and/or when the disease is complicated by other renal pathologies. Here, we present the case of a 33-year-old Japanese woman who had initially been diagnosed with IgA nephropathy but was found to have MIDD 6 years later. Two renal biopsies were conducted six years apart. While assessment of the first biopsy specimen with the monoclonal antibody (KM55) revealed mesangial IgA deposits (containing the galactose-deficient IgA1 variant [Gd-IgA1]), examination of the second specimen showed no mesangial IgA deposits and newly-developed glomerular global scleroses and tubular damage. Granular swollen epithelial cells (GSECs), characterised by abnormal mitochondria, were observed among the tubules and collecting ducts in both biopsy specimens. Mitochondrial DNA analysis revealed an m.3243A > G mutation. We rediscovered the usefulness of GSECs as a pathologically distinctive feature of mitochondrial nephropathy and reviewed the literature regarding MIDD complicated by mesangial IgA deposition. Furthermore, we demonstrate that the mesangial IgA deposits in this patient consisted of the galactose-deficient IgA1 variant. The monoclonal antibody (KM55) might be a useful tool to distinguish IgAN from latent IgA deposits.
- 10 December 2018
- Published by Springer Nature in BMC Nephrology
- Vol. 19 (1) , 350
Open AccessMaternally inherited diabetes and deafness complicated by mesangial galactose-deficient IgA1 deposits: a case report
Maternally inherited diabetes and deafness (MIDD), a mitochondrial genetic disorder, typically affects the kidneys and results in end-stage renal disease. Early diagnosis of MIDD is challenging when renal manifestations precede other key clinical features such as diabetes and deafness and/or when the disease is complicated by other renal pathologies. Here, we present the case of a 33-year-old Japanese woman who had initially been diagnosed with IgA nephropathy but was found to have MIDD 6 years later. Two renal biopsies were conducted six years apart. While assessment of the first biopsy specimen with the monoclonal antibody (KM55) revealed mesangial IgA deposits (containing the galactose-deficient IgA1 variant [Gd-IgA1]), examination of the second specimen showed no mesangial IgA deposits and newly-developed glomerular global scleroses and tubular damage. Granular swollen epithelial cells (GSECs), characterised by abnormal mitochondria, were observed among the tubules and collecting ducts in both biopsy specimens. Mitochondrial DNA analysis revealed an m.3243A > G mutation. We rediscovered the usefulness of GSECs as a pathologically distinctive feature of mitochondrial nephropathy and reviewed the literature regarding MIDD complicated by mesangial IgA deposition. Furthermore, we demonstrate that the mesangial IgA deposits in this patient consisted of the galactose-deficient IgA1 variant. The monoclonal antibody (KM55) might be a useful tool to distinguish IgAN from latent IgA deposits.